TrialJournal of the European Academy of Dermatology and Venereology : JEADV2020

Safety and efficacy of topical, fixed-dose combination calcipotriene (0.005%) and betamethasone (0.064% as dipropionate) gel in adolescent patients with scalp and body psoriasis: a phase II trial.

L F Eichenfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.